Suzhou Alphamab Co., Ltd.

This early-stage study tests a new drug called KN060 in 12 adults with end-stage kidney disease who need regular dialysis. The goal is to see if the drug is safe and can prevent blood clots from forming in the dialysis machine or the patient's blood vessels. Participants receive …

This study is testing a medicine called KN057 as a long-term preventive treatment for people with hemophilia A or B, including those whose bodies have developed inhibitors that make standard treatments less effective. About 70 participants aged 12 to 65 will receive weekly inject…

This early-stage study tests a new drug, KN060, for people with high blood pressure (hypertension). About 60 adults will receive either KN060 or a placebo by IV every two weeks for 12 weeks. The goal is to see if KN060 safely lowers blood pressure compared to placebo.

This early-stage study tests a new drug called KN069 in 36 Chinese men who are overweight or obese. The main goal is to check if the drug is safe and how the body processes it. Participants will receive either the drug or a placebo, and researchers will monitor weight, waist size…